Depistage neonatal de la mucoviscidose : vers une implementation nationale en Belgique en 2019. ; Neonatal screening for cystic fibrosis : towards a national implementation in Belgium in 2019
peer reviewed ; Cystic fibrosis has in Belgium a prevalence of 1/2.850 births, with a median age at diagnosis of 7 months according to the latest data from the Belgian registry of 2015. In our country, the diagnosis of cystic fibrosis is always based on signs and symptoms of the disease. However, because the scientific literature has largely demonstrated the benefits of neonatal screening for cystic fibrosis, it will be implemented in Belgium before the end of 2019. The screening programme should be framed by strict quality criteria in order to obtain the best performance with the least possib... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | journal article |
| Erscheinungsdatum: | 2018 |
| Verlag/Hrsg.: |
Université de Liège. Revue Médicale de Liège
|
| Schlagwörter: | Belgium / Newborn screening / Cystic fibrosis / Human health sciences / Pediatrics / Cardiovascular & respiratory systems / Sciences de la santé humaine / Pédiatrie / Systèmes cardiovasculaire & respiratoire |
| Sprache: | Französisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26551386 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://orbi.uliege.be/handle/2268/232328 |
peer reviewed ; Cystic fibrosis has in Belgium a prevalence of 1/2.850 births, with a median age at diagnosis of 7 months according to the latest data from the Belgian registry of 2015. In our country, the diagnosis of cystic fibrosis is always based on signs and symptoms of the disease. However, because the scientific literature has largely demonstrated the benefits of neonatal screening for cystic fibrosis, it will be implemented in Belgium before the end of 2019. The screening programme should be framed by strict quality criteria in order to obtain the best performance with the least possible inconvenience.